In the subgroup with 17p deletion or TP53 mutation, zanubrutinib outperformed others with the most favorable HR (0.52) and the highest SUCRA value of 97%.

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

From bipolar disorder to hepatitis, and from strokes to development of magnetic resonance imaging, research tied to NIH ...

Every day a child in Romania is diagnosed with cancer. Every day a family in our country enters the battle with a disease ...

Kevin’s mind relied on familiar pathways built by years of playing and coaching basketball. He used his analytical skills to ...

For those who attend a Fresno Pacific men’s basketball game, there’s a good chance they will see Tristen Graham riding the ...

Childhood cancer usually stems from genetic changes that occur randomly or are inherited, unlike adult cancers, which are ...

Medical experts emphasize the significance of early cancer detection. Learn about seven crucial warning signs that could ...

Scientists Identify Genes Linked to Relapse in the Most Common Form of Childhood Leukemia Aug. 12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in ...

Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate in ...